粉体光动力学损伤的纳米尺度图
Patricia Bondia1, Joaquim Torra1, Caterina M Tone1
1Madrid Institute for Advanced Studies in Nanoscience (IMDEA Nanociencia) , C/Faraday 9 , Madrid 28049 , Spain.
Journal of the American Chemical Society
|November 30, 2019
概括
研究人员研究了光催化剂如何与粉样聚合物结合以及光照后的效果. 这项工作通过了解光降解机制来推进粉样蛋白相关疾病的光疗策略.
科学领域:
- 生物物理
- 材料科学
- 摄影化学
背景情况:
- 氨基酸聚合物与各种神经退行性疾病有关.
- 光催化剂为粉样蛋白疾病提供了潜在的治疗策略.
- 了解光催化剂-粉样相互作用对于治疗发展至关重要.
研究的目的:
- 研究光催化剂与粉样纤维的结合.
- 阐明光催化剂辐射对粉体聚合物的后果.
- 探索与粉样蛋白相关疾病的光动力疗法的潜力.
主要方法:
- 时间解析的光学光谱.
- 相对原子力显微镜 (AFM) 和光显微镜.
- 探测近红外 (NIR) 光对单片氧.
主要成果:
- 观察到光催化剂与模型β- 乳球蛋白纤维的地形依赖性结合.
- 通过光催化剂与粉样纤维结合获得单片氧光敏感化的直接证据.
- 在单片氧暴露时检测到单个粉样纤维的纳米级形态变化.
- 在两个α-synuclein突变体中观察到不同的光损伤反应.
结论:
- 这项研究揭示了复杂的光催化剂-粉体相互作用和光降解机制.
- 这些发现有助于揭示粉样蛋白种群的异质性.
- 结果支持对粉样蛋白疾病的改善光疗策略的开发.
更多相关视频
相关概念视频
Amyloid Fibrils
11.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
11.5K
Amyloid Fibrils
6.2K
6.2K


